River Stone Biotech Overview

  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private

River Stone Biotech General Information

Description

Owner and operator of an integrated synthetic biology company intended to improve the production and performance of pharmaceuticals. The company focuses on areas like molecules from synthetic chemistry, manufacturing process, tissue targeting, tissue absorption and other related areas, enabling clients to make affordable, higher purity and specific enantiomers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

River Stone Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-May-2017 Completed Generating Revenue
1. Early Stage VC 01-Mar-2015 Completed Startup
To view River Stone Biotech’s complete valuation and funding history, request access »

River Stone Biotech Executive Team (4)

Name Title Board Seat Contact Info
Paul Goldenheim Chief Executive Officer
Jørgen Hansen Chief Scientific Officer
Nethaji Gallage Ph.D Executive
Neil Goldsmith Chief Business Officer
To view River Stone Biotech’s complete executive team members history, request access »